HERON THERAPEUTICS, INC. /DE/ (HRTX) Insider Trading

Name: HERON THERAPEUTICS, INC. /DE/ (HRTX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 10, 2026): Mark Earl Hensley (Chief Operating Officer): Exercise/Conversion of 31,250 shares.

Get alerted when insiders trade HRTX

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta